儿童过敏和喘的替代症
Angela Klain1, Mattia Giovannini2,3, Stefania Arasi4
1Department of Woman, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
Medicina (Kaunas, Lithuania)
|September 27, 2025
概括
Alternaria alternata是一种常见的真菌过敏原,与儿童喘和过敏性鼻炎有关. 早期诊断和过敏原免疫疗法 (AIT) 对管理这种过敏有希望.
科学领域:
- * 菌类学和免疫学
- * 儿科过敏和呼吸系统医学
背景情况:
- *Alternaria alternata是儿童的重要真菌过敏原,与环境和遗传因素相关的敏感性增加率.
- *它与儿童喘和过敏性鼻炎的发展和恶化密切相关,经常导致严重的疾病.
- * 主要的过敏原Alt a1在Alternaria诱导的过敏中是关键的,并且可以引起与其他真菌的交叉反应.
研究的目的:
- * 为提供对儿童Alternaria过敏的全面概述.
- *讨论流行病学,免疫病原发生,临床影响,诊断挑战和治疗选择.
- * 支持早期识别和个性化治疗策略,以治疗Alternaria过敏.
主要方法:
- *对当前关于儿童群体中Alternaria过敏的科学文献的综述.
- * 诊断方法的分析,包括传统的测试和组件解决诊断.
- *对过敏原免疫疗法 (AIT) 疗效和局限性的评估.
主要成果:
- *由于可变的真菌提取物,诊断Alternaria过敏是具有挑战性的;组件解决的诊断和鼻刺激测试可能是有益的.
- *使用标准化的Alt a 1提取物或过敏剂的过敏原免疫疗法 (AIT) 显示出临床和免疫学的潜在益处.
- *由于商业产品和长期数据有限,AIT在儿科Alternaria过敏中未得到充分利用.
结论:
- *Alternaria alternata过敏是儿科呼吸系统健康的一个关键问题.
- * 需要改进的诊断方法和标准化的AIT才能有效管理.
- *对儿童的AIT疗效和可用性进行进一步的研究是必不可少的.
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Allergic Reactions
32.0K
Overview
32.0K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K


